This is a news story, published by TechCrunch, that relates primarily to Nandakumar news.
For more Nandakumar news, you can click here:
more Nandakumar newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from TechCrunch, you can click here:
more news from TechCrunchOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Ashwin Nandakumar. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest name Ashwin news, bio partner news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Ashwin JainarayananTechCrunch
•83% Informative
Ashwin Nandakumar and Ashwin Jainarayanan formed Granza Bio , a biotech startup.
The startup is working on a novel approach to delivering immunotherapy and other “attack particles” to various parts of the body.
Granza 's approach could have broad applications in oncology and autoimmune disease treatment.
The two Ashwins entered the YC Winter 24 batch.
VR Score
84
Informative language
85
Neutral language
46
Article tone
formal
Language
English
Language complexity
59
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
2
Source diversity
2
Affiliate links
no affiliate links